BiotechTube

Levetiracetam + Placebo

Phase 3Terminated
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Epilepsy, Post-Traumatic

Conditions

Epilepsy, Post-Traumatic

Trial Timeline

Nov 1, 2007 → May 1, 2010

NCT ID
NCT00566046

About Levetiracetam + Placebo

Levetiracetam + Placebo is a phase 3 stage product being developed by UCB for Epilepsy, Post-Traumatic. The current trial status is terminated. This product is registered under clinical trial identifier NCT00566046. Target conditions include Epilepsy, Post-Traumatic.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (6)

NCT IDPhaseStatus
NCT00291213Phase 3Completed
NCT01228747Phase 3Completed
NCT00566046Phase 3Terminated
NCT00291733Phase 2UNKNOWN
NCT00254657Pre-clinicalCompleted
NCT00615615Phase 3Completed

Competing Products

20 competing products in Epilepsy, Post-Traumatic

See all competitors
ProductCompanyStageHype Score
perampanelEisaiPhase 2
52
LacosamideUCBPhase 3
74
Zonisamide + PlaceboEisaiPhase 3
77
ZonegranEisaiApproved
85
perampanel + perampanelEisaiPhase 1
33
Perampanel + PlaceboEisaiApproved
85
perampanelEisaiApproved
85
E2007 + PlaceboEisaiPhase 2
52
Placebo + RufinamideEisaiPhase 3
77
E2007 (perampanel) + PlaceboEisaiPhase 2
52
Perampanel Oral TabletEisaiApproved
85
perampanelEisaiPhase 3
77
PerampanelEisaiPre-clinical
23
Zonisamide + CarbamazepineEisaiPhase 3
77
PerampanelEisaiApproved
85
Perampanel and Microgynon-30 + Perampanel and Microgynon-30EisaiPhase 1
33
PerampanelEisaiPhase 2
52
Zonisamide + PlaceboEisaiPhase 3
77
zonisamide low dose group + zonisamide high dose groupEisaiApproved
85
E2007 + E2007 + PlaceboEisaiPhase 2
52

Other Products from UCB

LevetiracetamApproved
82
Parcopa + carbidopa-levodopa (Sinemet)Approved
82
LevocetirizineApproved
82
RotigotineApproved
82
Levetiracetam + OxcarbazepineApproved
82